Journal article
Retraction notice to "The Procognitive and Synaptogenic Effects of Angiotensin IV-Derived Peptides Are Dependent on Activation of the Hepatocyte Growth Factor/c-Met System" [J Pharmacol Exp Ther 351 (2014) 390-402]
The Journal of pharmacology and experimental therapeutics, 2025 Apr. Benoist CC, Kawas LH, Zhu M and 6 others.
Study type
Journal article
Subjects
Not classified in PubMed MeSH
Journal
The Journal of pharmacology and experimental therapeutics
Published
2025 Apr
PubMed
Where PepCue cites this
This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.
Other papers on Dihexa
Review · 2015
The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases
Journal article · 2013Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents
PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.
Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page